These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24658651)

  • 1. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
    Goto H; Tokunaga M; Miki Y; Makuuchi R; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
    Gastric Cancer; 2014 Mar; 18(2):375-81. PubMed ID: 24658651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.
    Cai MZ; Lv CB; Cai LS; Chen QX
    Medicine (Baltimore); 2019 Dec; 98(51):e18451. PubMed ID: 31861019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
    Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
    Front Oncol; 2021; 11():748694. PubMed ID: 34926257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Adenocarcinoma.
    Peng J; Wang WP; Yuan Y; Hu Y; Wang Y; Chen LQ
    Ann Thorac Surg; 2015 Jul; 100(1):263-9. PubMed ID: 25980597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study.
    Qi X; Liu M; Xu K; Tan F; Gao P; Yao Z; Zhang N; Yang H; Zhang C; Xing J; Cui M; Su X
    Surg Endosc; 2024 Jul; 38(7):3828-3837. PubMed ID: 38822144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Goto H; Tokunaga M; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
    Gastric Cancer; 2013 Oct; 16(4):590-5. PubMed ID: 23179369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 13. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
    [No Abstract]   [Full Text] [Related]  

  • 14. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
    Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
    Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of total laparoscopic radical resection of Siewert type II gastroesophageal junction adenocarcinoma through the left diaphragm and left thoracic auxiliary hole.
    Huang Y; Liu G; Wang X; Zhang Y; Zou G; Zhao Z; Cao Z; Zhao H; Yuan X; Zhang C
    World J Surg Oncol; 2021 Mar; 19(1):73. PubMed ID: 33714262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
    Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
    Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study.
    Li J; Xiong W; Ou H; Yang T; Jiang S; Huang H; Zheng Y; Luo L; Peng X; Wang W
    Surg Endosc; 2024 Apr; 38(4):1986-1994. PubMed ID: 38381159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns and influencing factors of lymph node metastasis of adenocarcinoma of the esophagogastric junction in 393 patients].
    Zhang YJ; Wang J; Zhang XL; Liu Q; Jing SW; Wang Y; Cao F; Jiao WP
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):672-6. PubMed ID: 27647399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.